Lundbeck
HLUN-B.CO
#2789
Rank
C$6.36 B
Marketcap
$6.61
Share price
-1.37%
Change (1 day)
1.69%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.50. In 2022 the company made an earnings per share (EPS) of $0.38 a decrease over its 2021 EPS that were of $0.85.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4826.01%
2022$0.38-55.47%
2021$0.85-51.83%
2020$1.77-28.01%
2019$2.45-44.08%
2018$4.3951.94%
2017$2.89126.64%
2016$1.27-120.84%
2015-$6.125622.18%
2014-$0.11-110.03%
2013$1.07-28.08%
2012$1.48-52.1%
2011$3.09-1.31%
2010$3.1315.61%
2009$2.71